OSTEOPORE LIMITED — Director's Dealing 2023

Jul 30, 2023

==> picture [145 x 59] intentionally omitted <==

31 July 2023

Ms Vanessa Nevjestic Senior Adviser, Listings Compliance ASX 152-158 St Georges Terrace Perth WA 6000

Dear Ms Nevjestic,

Osteopore Limited Appendix 3X – Initial Director’s Interest Notice for Michael Keenan

Osteopore Limited ( ASX:OSX ) (“ Osteopore ” or the “ Company ”) attaches an Appendix 3X ‘Initial Director’s Interest Notice’ for Mr Michael Keenan who was appointed as a Non-Executive Director of the Company on 18 July 2023.

Having regard to ASX Listing Rules 3.19A and 3.19B and Guidance Note 22: "Director Disclosure of Interests and Transactions in Securities - Obligations of Listed Entities", the Company makes the following submissions in relation to the late lodgement of this Appendix 3X ‘Initial Director’s Interest Notice’ for Mr Michael Keenan:

1. The Appendix 3X ‘Initial Director’s Interest Notice’ for Mr Keenan was prepared at the time of Mr Keenan’s appointment but was not lodged due to an administrative oversight. Upon being identified by the Company, the notice has been immediately lodged. The Company confirms that it is aware of and understands its obligations under the Corporations Act 2001 (Cth) and the ASX Listing Rules, in particular the obligations under ASX Listing Rules 3.19A and 3.19B.

2. The Company and its Directors are aware of their obligations under ASX Listing Rule 3.19A. Each Director is made aware of this obligation pursuant to their terms of appointment, which includes a requirement that a director disclose to the Company all information required by the Company to give ASX completed Appendices 3X, 3Y and 3Z within the time period allowed by Listing Rule 3.19.A.

3. The Company’s existing arrangements are considered adequate and the late lodgement of this particular Appendix 3X notice was an isolated incident. The Company is mindful of its disclosure obligations under ASX Listing Rule 3.19A.1.

Yours faithfully

Kellie Davis Company Secretary

Osteopore Limited (ACN 630 538 957) ASX:OSX│ Level 5, 191 St. Georges Terrace, Perth WA 6000│ PO Box 7059, Cloisters Square PO, Perth WA 6850│+61 2 8072 1400│www.osteopore.com

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Osteopore Limited

ABN 65 630 538 957

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Michael Keenan
Date of appointment	18 July 2023

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

• See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of Number & class of Securities interest Note: Provide details of the circumstances giving rise to the relevant interest. - -

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
No. and class of securities to which interest relates	N/A

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002